These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 25918215

  • 1. Failure of ivermectin per rectum to achieve clinically meaningful serum levels in two cases of Strongyloides hyperinfection.
    Bogoch II, Khan K, Abrams H, Nott C, Leung E, Fleckenstein L, Keystone JS.
    Am J Trop Med Hyg; 2015 Jul; 93(1):94-6. PubMed ID: 25918215
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA, Maclean JD, Fleckenstein L, Greenaway C.
    Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
    [Abstract] [Full Text] [Related]

  • 6. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
    Manrique-Rodríguez S, Martín-Rabadán P, Díaz-Cámara M, Fernández-Llamazares CM.
    Med Clin (Barc); 2016 Apr 15; 146(8):376-7. PubMed ID: 26654554
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Successful use of subcutaneous ivermectin for the treatment of Strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population.
    Zeitler K, Jariwala R, Restrepo-Jaramillo R, Kapadia S, Casanas B, Alrabaa S, Sriaroon C.
    BMJ Case Rep; 2018 Jun 04; 2018():. PubMed ID: 29866667
    [Abstract] [Full Text] [Related]

  • 11. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
    Moura EB, Maia Mde O, Ghazi M, Amorim FF, Pinhati HM.
    Braz J Infect Dis; 2012 Jun 04; 16(5):479-81. PubMed ID: 22975175
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fatal outcome of a hyperinfection syndrome despite successful eradication of Strongyloides with subcutaneous ivermectin.
    Hauber HP, Galle J, Chiodini PL, Rupp J, Birke R, Vollmer E, Zabel P, Lange C.
    Infection; 2005 Oct 04; 33(5-6):383-6. PubMed ID: 16258873
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P, Rosa-Cunha I, Morris M, Nishida S, Akpinar E, Gaitan J, Tzakis A, Doblecki-Lewis S.
    Transpl Infect Dis; 2009 Apr 04; 11(2):137-42. PubMed ID: 19144097
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.